Galmed CEO outlines drug development plans in shareholder letter
Go back to Galmed CEO outlines drug development plans in shareholder letter| GALMED PHARMACEUTIC (NASDAQ: GLMD) | Delayed: 4.31 +0.01 (0.23%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $4.30 | 52 Week High | $9.70 | |||
| Open | $4.31 | 52 Week Low | $2.78 | |||
| Day High | $4.31 | P/E | N/A | |||
| Day Low | $4.31 | EPS | $0.00 | |||
| Volume | 1,315 | |||||
